Exploring the utility of serum anti-tNASP antibodies as a screening biomarker in prostate, pancreatic, and ovarian cancer

O. M. Alekseev, X. Yi, M. Kasmenn, S. Kundu, M. Rogers, Z. Vaskalis

Research output: Contribution to journal › Article › peer-review

Disciplines

@article{22222eb0894e48199454026afb6c684e,

title = "Exploring the utility of serum anti-tNASP antibodies as a screening biomarker in prostate, pancreatic, and ovarian cancer",

author = "Alekseev, {O. M.} and X. Yi and M. Kasmenn and S. Kundu and M. Rogers and Z. Vaskalis",

year = "2023",

month = oct,

day = "1",

doi = "10.1016/j.annonc.2023.09.2879",

language = "American English",

volume = "34",

journal = "Annals of Oncology",

}

TY - JOUR

T1 - Exploring the utility of serum anti-tNASP antibodies as a screening biomarker in prostate, pancreatic, and ovarian cancer

AU - Alekseev, O. M.

AU - Yi, X.

AU - Kasmenn, M.

AU - Kundu, S.

AU - Rogers, M.

AU - Vaskalis, Z.

PY - 2023/10/1

Y1 - 2023/10/1

UR - https://cufind.campbell.edu/medicine_school/2195

UR - https://doi.org/10.1016/j.annonc.2023.09.2879

U2 - 10.1016/j.annonc.2023.09.2879

DO - 10.1016/j.annonc.2023.09.2879

M3 - Article

VL - 34

JO - Annals of Oncology

JF - Annals of Oncology

ER -